# CISATRACURIUM BESYLATE PRESERVATIVE FREE
> **ANDA203182** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2015-02-26
## Drug
- **FDA Application Number:** ANDA203182
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CISATRACURIUM BESYLATE PRESERVATIVE FREE
- **Generic name:** CISATRACURIUM BESYLATE
- **Active ingredients:** CISATRACURIUM BESYLATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2015-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203182)
---
*AI Analytics · CC0 1.0*